Sentinel node biopsy confers no added protection to patients with melanoma

What is it about?

A “surgical” staging procedure in any cancer becomes essential when it provides unique information that influences the management of a particular cancer to the benefit and welfare of the patient. This paper argues that sentinel node biopsy applied to patients with cutaneous melanoma does not meet the criteria for this essential qualification. It also argues that the prognostic resources of the primary lesion have not hitherto been fully exploited.

Featured Image